跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
枸橼酸托法替布缓释片 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Tofacitinib Citrate Sustained-release Tablets
Approved
化学药品
Tofacitinib Citrate Sustained-release Tablets
PFIZER INC.
🇨🇳 National Medical Products Administration
Approval Date
Sep 7, 2021
Approval ID
8BYsm6a6Rnv
Company
PFIZER INC.
Type
化学药品
Approval Details
Approval Id
8BYsm6a6Rnv
Approval Number
国药准字HJ20210071
Generic Name
枸橼酸托法替布缓释片
Generic Name En
Tofacitinib Citrate Sustained-release Tablets
Drug Type
化学药品
Dosage Form
缓释片
Strength
11mg（按C₁₆H₂₀N₆O计）
Reg Date
2021-09-07
Expired Date
2026-09-06
Company Name
PFIZER INC.
Production Company Name
Viatris Pharmaceuticals LLC
Company Detail Path
/organization/pfizer-inc
Production Company Detail Path
/organization/viatris-pharmaceuticals-llc
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Sep 7, 2021
Approval ID
8BYsm6a6Rnv
Type
化学药品
Back to NMPA Approvals
